(RXI) |
| 0 (0%) 09-16 01:58 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 205.37 |
| Resistance 1: | 198.97 |
| Pivot price: | 195.20 |
| Support 1: | 188.61 |
| Support 2: | 156.92 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 14 Sep 2026
Discipline and Rules-Based Execution in RXI Response - Stock Traders Daily
Thu, 02 Jan 2025
RXI-231 May Help Fade Hyperpigmentation - The Dermatology Digest
Thu, 19 Jan 2023
Riyadh All-Stars 4-5 PSG (Jan 19, 2023) Final Score - ESPN
Thu, 13 May 2021
Meet RXI, the Revolutionary Real-time Risk Intelligence Solution - Finance Magnates
Wed, 12 May 2021
CloudMD Closes Acquisition of Rxi, Providing an Established - GlobeNewswire
Thu, 16 Aug 2018
RXi and Karolinska Institutet target solid tumour therapy - Pharmaceutical Technology
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
